Search

Your search keyword '"Sailer, Verena"' showing total 282 results

Search Constraints

Start Over You searched for: Author "Sailer, Verena" Remove constraint Author: "Sailer, Verena"
282 results on '"Sailer, Verena"'

Search Results

13. CEACAM6 Promotes Lung Metastasis via Enhancing Proliferation, Migration and Suppressing Apoptosis of Prostate Cancer Cells.

16. FIGURE 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

17. Supplementary Figure 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

18. Supplementary Data Legends from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

19. Supplementary Table 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

20. FIGURE 5 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

21. FIGURE 3 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

22. Supplementary Figure 3 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

23. FIGURE 4 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

24. Supplementary Figure 2 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

25. FIGURE 2 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

26. Data from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

27. The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

28. Metastatic Prostate Cancer

29. Data from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

30. Supplementary Table 7 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

31. Supplementary Figures 1 - 6 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

32. Supplementary Table 1 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

33. Supplementary Table 3 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

34. Supplementary Table Legends from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

35. Supplementary Table 2 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

36. Supplementary Table 6 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

37. Supplementary Table 4 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

38. Supplementary Table 5 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

39. Supplementary Data from A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

41. Long-term taxane exposure and transdifferentiation of prostate cancer in vitro.

43. Experimental in vitro, ex vivo and in vivo models in prostate cancer research

45. The Gene Expression Landscape of Prostate Cancer BM Reveals Close Interaction with the Bone Microenvironment

47. Targeting cyclin-dependent kinase 7—association between CDK7 and pMED1 expression in prostate cancer tissue

48. Bone biopsy protocol for advanced prostate cancer in the era of precision medicine

50. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci

Catalog

Books, media, physical & digital resources